ZAPARDA
Live / Registered — Registered (as of 16 Nov 2021)
What this means for you
Registered since 16 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88600317
- Registration number
- 6557732
- Mark type
- Stylized text
- Filed
- 30 Aug 2019
- Published for opposition
- 31 Aug 2021
- Registered
- 16 Nov 2021
- Attorney of record
- Sandra Epp Ryan
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment of skin disorders associated with Tuberous sclerosis
- Class 042 — Scientific and technological services: (Based on 44(e)) Scientific investigations for medical purposes; Scientific research; Medical research; Scientific research and development; Scientific laboratory services
- Class 044 — Medical, beauty and agricultural services: (Based on 44(e)) Medical clinic services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Owner
- Nobelpharma Co., Ltd., Tokyo, JP
- Nobelpharma Co., Ltd., Tokyo, JP
- Nobelpharma Co., Ltd., Tokyo, JP
Prosecution history
- 16 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 31 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Aug 2021 — PUBLISHED FOR OPPOSITION
- 11 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jul 2021 — CASE RETURNED TO EXAMINATION
- 26 Jul 2021 — NOTICE OF ALLOWANCE CANCELLED
- 20 Jul 2021 — ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
- 20 Jul 2021 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 23 Jun 2021 — ASSIGNED TO PETITION STAFF
- 14 Jun 2021 — ASSIGNED TO EXAMINER
- 26 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2021 — SOU EXTENSION 1 GRANTED
- 24 May 2021 — SOU EXTENSION 1 FILED
- 24 May 2021 — SOU TEAS EXTENSION RECEIVED
- 24 May 2021 — TEAS POST PUBLICATION AMENDMENT RECEIVED